Daré Bioscience Inc. (DARE)
NASDAQ: DARE
· Real-Time Price · USD
2.10
-0.10 (-4.55%)
At close: Aug 18, 2025, 3:59 PM
2.08
-0.95%
Pre-market: Aug 19, 2025, 05:04 AM EDT
-4.55% (1D)
| Bid | 2.08 |
| Market Cap | 18.59M |
| Revenue (ttm) | 25.91K |
| Net Income (ttm) | -1.68M |
| EPS (ttm) | -0.17 |
| PE Ratio (ttm) | -12.35 |
| Forward PE | -1.52 |
| Analyst | Buy |
| Ask | 2.16 |
| Volume | 145,208 |
| Avg. Volume (20D) | 1,551,308 |
| Open | 2.17 |
| Previous Close | 2.20 |
| Day's Range | 2.10 - 2.29 |
| 52-Week Range | 1.83 - 9.19 |
| Beta | 1.11 |
About DARE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DARE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DARE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Daré Bioscience Inc. is scheduled to release its earnings on
Nov 13, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+22.62%
Dare Bioscience shares are trading higher after th...
Unlock content with
Pro Subscription
1 month ago
+5.44%
DARE stock has given up its prior gain. Daré Bioscience shares were trading higher after the company received a $6 million non-dilutive grant installment under its agreement to support DARE-LARC1.
